NM_002800.5:c.26G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_002800.5(PSMB9):​c.26G>A​(p.Gly9Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,534,740 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G9R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0082 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 63 hom. )

Consequence

PSMB9
NM_002800.5 missense

Scores

2
15

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.36

Publications

5 publications found
Variant links:
Genes affected
PSMB9 (HGNC:9546): (proteasome 20S subunit beta 9) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 1 (proteasome beta 6 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. [provided by RefSeq, Mar 2010]
PSMB9 Gene-Disease associations (from GenCC):
  • proteasome-associated autoinflammatory syndrome 3
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041626394).
BP6
Variant 6-32854255-G-A is Benign according to our data. Variant chr6-32854255-G-A is described in ClinVar as Benign. ClinVar VariationId is 3044101.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0082 (1249/152318) while in subpopulation AFR AF = 0.026 (1081/41574). AF 95% confidence interval is 0.0247. There are 22 homozygotes in GnomAd4. There are 636 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB9NM_002800.5 linkc.26G>A p.Gly9Glu missense_variant Exon 1 of 6 ENST00000374859.3 NP_002791.1 P28065-1A0A1U9X8D7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB9ENST00000374859.3 linkc.26G>A p.Gly9Glu missense_variant Exon 1 of 6 1 NM_002800.5 ENSP00000363993.2 P28065-1
PSMB9ENST00000464863.1 linkn.108G>A non_coding_transcript_exon_variant Exon 1 of 3 2
PSMB9ENST00000395330.6 linkc.-9-1883G>A intron_variant Intron 1 of 5 3 ENSP00000378739.1 A2ACR1
PSMB9ENST00000414474.5 linkc.-9-1883G>A intron_variant Intron 1 of 4 5 ENSP00000394363.1 A2ACR0

Frequencies

GnomAD3 genomes
AF:
0.00821
AC:
1249
AN:
152200
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0261
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0180
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00559
AC:
760
AN:
136046
AF XY:
0.00635
show subpopulations
Gnomad AFR exome
AF:
0.0303
Gnomad AMR exome
AF:
0.00186
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000298
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000338
Gnomad OTH exome
AF:
0.00503
GnomAD4 exome
AF:
0.00244
AC:
3368
AN:
1382422
Hom.:
63
Cov.:
31
AF XY:
0.00297
AC XY:
2023
AN XY:
682200
show subpopulations
African (AFR)
AF:
0.0305
AC:
929
AN:
30442
American (AMR)
AF:
0.00174
AC:
55
AN:
31684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23584
East Asian (EAS)
AF:
0.000198
AC:
7
AN:
35266
South Asian (SAS)
AF:
0.0237
AC:
1822
AN:
76774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48010
Middle Eastern (MID)
AF:
0.00219
AC:
11
AN:
5026
European-Non Finnish (NFE)
AF:
0.000331
AC:
356
AN:
1074336
Other (OTH)
AF:
0.00328
AC:
188
AN:
57300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
175
351
526
702
877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00820
AC:
1249
AN:
152318
Hom.:
22
Cov.:
32
AF XY:
0.00854
AC XY:
636
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0260
AC:
1081
AN:
41574
American (AMR)
AF:
0.00359
AC:
55
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5166
South Asian (SAS)
AF:
0.0180
AC:
87
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68018
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00476
Hom.:
6
Bravo
AF:
0.00852
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0202
AC:
59
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00371
AC:
405
Asia WGS
AF:
0.0220
AC:
76
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PSMB9-related disorder Benign:1
Mar 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.12
N
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.4
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.028
Sift
Benign
0.032
D
Sift4G
Benign
0.26
T
Vest4
0.23
MVP
0.40
MPC
0.53
ClinPred
0.0055
T
GERP RS
3.1
PromoterAI
0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.092
gMVP
0.59
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35100697; hg19: chr6-32822032; COSMIC: COSV107445381; COSMIC: COSV107445381; API